Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CBL inhibitors and compositions for use in adoptive cell therapy

CBL inhibitors and compositions for use in adoptive cell therapy

US Patent 12121540 · Granted Oct 22, 2024

Estimated economic value: $32,520,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
Piperidinylpyrazine-carboxamide compounds for treating and preventing cancer and2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2025
Triple combination antibody therapies2024
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof2024
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof2024
Combination therapies with Cbl-b inhibitor compounds2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2024
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2024
Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating can2024